ARTICLE | Financial News
Aslan raises $34M in series C round
December 8, 2015 2:33 AM UTC
Aslan Pharmaceuticals Pte. Ltd. (Singapore) raised $34 million in a series C round led by the Accuron Technologies Ltd. subsidiary of Temasek Holdings. New investors Tianda Pharmaceuticals Ltd. (Hong Kong, China) and Haitong International also participated, as did existing investors Morningside Group, BioVeda Capital, Cenova Ventures and Sagamore Bioventures. ...